Article By:
Bio Deep Dives
Thursday, May 18, 2023 4:13 PM EDT
The FTC suit against Amgen appears to be a clear case of regulatory overreach but what this ultimately means will take time to fully develop.
Market Briefing For Wednesday, Aug.25
How much will #Amgen pay to acquire #Sorrento? 🤔
$SRNE $AMGN
July 2017 Stock Considerations
I read that #Repatha sales for this quarter are down significantly so be careful with $AMGN.